Drug-induced Immune Thrombocytopenia

被引:24
|
作者
Chong, Beng H. [1 ,2 ]
Choi, Philip Young-Ill [2 ,3 ]
Khachigian, Levon [3 ]
Perdomo, Jose [2 ,3 ]
机构
[1] St George Hosp, Dept Haematol, Kogarah, NSW 2217, Australia
[2] Univ New S Wales, St George Hosp, Dept Med, St George Clin Sch, Kogarah, NSW 2217, Australia
[3] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2033, Australia
关键词
Drugs; Thrombocytopenia; Immune; Antibodies; QUININE-INDUCED THROMBOCYTOPENIA; HEPARIN-INDUCED THROMBOCYTOPENIA; PLATELET GLYCOPROTEIN IIB/IIIA; DEPENDENT ANTIBODIES; PROFOUND THROMBOCYTOPENIA; IN-VITRO; ANTIPLATELET ANTIBODIES; NONCYTOTOXIC DRUGS; NOD/SCID MOUSE; BINDING-SITE;
D O I
10.1016/j.hoc.2013.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thrombocytopenia is caused by immune reactions elicited by diverse drugs in clinical practice. The activity of the drug-dependent antibodies produces a marked decrease in blood platelets and a risk of serious bleeding. Understanding of the cellular mechanisms that drive drug-induced thrombocytopenia has advanced recently but there is still a need for improved laboratory tests and treatment options. This article provides an overview of the different types of drug-induced thrombocytopenia, discusses potential pathologic mechanisms, and considers diagnostic methods and treatment options.
引用
收藏
页码:521 / +
页数:21
相关论文
共 50 条
  • [1] Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia
    Vayne, Caroline
    Guery, Eve-Anne
    Rollin, Jerome
    Baglo, Tatiana
    Petermann, Rachel
    Gruel, Yves
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 19
  • [2] A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia
    Arnold, D. M.
    Kukaswadia, S.
    Nazi, I.
    Esmail, A.
    Dewar, L.
    Smith, J. W.
    Warkentin, T. E.
    Kelton, J. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) : 169 - 176
  • [3] Idiosyncratic drug-induced thrombocytopenia
    Serraj, K.
    Mecili, M.
    Aouni, M.
    Maaouni, A.
    Andres, E.
    REVUE DE MEDECINE INTERNE, 2009, 30 (10): : 866 - 871
  • [4] Acute drug-induced immune thrombocytopenia - A work of articaine
    Laegreid, Ingvild Jenssen
    Olsen, Mats Irgen
    Harr, Jon Inge
    Gronli, Renathe Henriksen
    Mortberg, Trude Victoria
    Ernstsen, Siw Leiknes
    Ahlen, Maria Therese
    TRANSFUSION, 2022, 62 (05) : 1142 - 1147
  • [5] Drug-Induced Immune Thrombocytopenia
    Patricia M. L. A. van den Bemt
    Ronald H. B. Meyboom
    Antoine C. G. Egberts
    Drug Safety, 2004, 27 : 1243 - 1252
  • [6] Recognition and management of drug-induced cytopenias: the example of idiosyncratic drug-induced thrombocytopenia
    Andres, Emmanuel
    Dali-Youcef, Nassim
    Serraj, Khalid
    Zimmer, Jacques
    EXPERT OPINION ON DRUG SAFETY, 2009, 8 (02) : 183 - 190
  • [7] Drug-Induced Thrombocytopenia: Mechanisms and Laboratory Diagnostics
    Danese, Elisa
    Montagnana, Martina
    Favaloro, Emmanuel J.
    Lippi, Giuseppe
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2020, 46 (03) : 264 - 274
  • [8] Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia
    Arnold, Donald M.
    Nazi, Ishac
    Warkentin, Theodore E.
    Smith, James W.
    Toltl, Lisa J.
    George, James N.
    Kelton, John G.
    TRANSFUSION MEDICINE REVIEWS, 2013, 27 (03) : 137 - 145
  • [9] DRUG-INDUCED THROMBOCYTOPENIA
    MERVYN, A
    SAHUD, MD
    SHEILAFLAHERTY, BS
    PATHOLOGIE BIOLOGIE, 1994, 42 (08): : 806 - 806
  • [10] Drug-induced thrombocytopenia in critically ill patients
    Priziola, Jennifer L.
    Smythe, Maureen A.
    Dager, William E.
    CRITICAL CARE MEDICINE, 2010, 38 : S145 - S154